The Latest Research in Multiple Myeloma, Leukemia and Other Blood Cancers

Cancer research, multiple myeloma

Irene Ghobrial, MD

The last two years have been very exciting for blood cancer research; many new targeted therapies and immunotherapies are improving treatment outcomes for patients with lymphoma, leukemia and multiple myeloma.

“We’re starting to see a lot of hematologic malignancies benefit from immunotherapy,” says Irene Ghobrial, MD. “The excitement is there for so many trials and several new drug combinations that are being tested right now.”

Ghobrial recently joined Matthew Davids, MD, for a live video webchat on the latest in blood cancer research. Ghobrial and Davids, who are both medical oncologists and researchers with Dana-Farber’s Hematologic Oncology Treatment Center, discussed new treatments and clinical trials, as well as highlights from the recent American Society of Hematology (ASH) Annual Meeting.

Two focus areas for Davids and Ghobrial, chronic lymphocytic leukemia (CLL) and multiple myeloma, have seen a surge in new treatments. Six new drugs have been approved for these two diseases in the last two years alone, and more are in the pipeline.

“In CLL, we’ve had several exciting new drugs come along that are mainly monotherapy (one drug at a time), but the future is going to be combining drugs,” Davids says. “We don’t know yet if it’s better to combine these new (monotherapeutic) drugs with each other or with chemotherapy, but I think both strategies should be explored and that’s what we’re looking at now.”

Learn more by watching a recording of the webchat below:

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
RT @DanaFarberYAP: Head over to @DanaFarber's Facebook page on 8/28 @1PM for a Live Q&A about being a young adult with cancer: https://t.co
Dana-Farber @danafarber
1 in 5 Americans will develop #skincancer at some point in their lifetime. Do you know the signs?… https://t.co/gOk6id2IrX
Dana-Farber @danafarber
Help support adolescent and young adult cancer legislation in Congress! Take action now: https://t.co/czzIGnLw5T

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.